journal
https://read.qxmd.com/read/38594061/medicines-and-global-warming-a-complex-problem
#1
EDITORIAL
James A Cave
No abstract text is available yet for this article.
April 9, 2024: Drug and Therapeutics Bulletin
https://read.qxmd.com/read/38594060/mhra-issues-further-update-on-fluoroquinolone-safety
#2
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
April 9, 2024: Drug and Therapeutics Bulletin
https://read.qxmd.com/read/38580400/donanemab-in-early-symptomatic-alzheimer-s-disease
#3
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
April 5, 2024: Drug and Therapeutics Bulletin
https://read.qxmd.com/read/38519120/recent-updates-from-the-bnf-bnf-87
#4
JOURNAL ARTICLE
(no author information available yet)
The BNF is jointly published by the Royal Pharmaceutical Society and BMJ. BNF is published in print twice a year and interim updates are issued and published monthly in the digital versions. The following summary provides a brief description of some recent key changes that have been made to BNF content.
March 22, 2024: Drug and Therapeutics Bulletin
https://read.qxmd.com/read/38458656/do-regulatory-safety-warnings-on-medicines-miss-the-mark
#5
EDITORIAL
Barbara Mintzes
No abstract text is available yet for this article.
March 8, 2024: Drug and Therapeutics Bulletin
https://read.qxmd.com/read/38417949/safety-update-valproate-safety-and-educational-materials
#6
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
February 28, 2024: Drug and Therapeutics Bulletin
https://read.qxmd.com/read/38346850/protecting-consumers-a-rich-legacy
#7
EDITORIAL
David Phizackerley
No abstract text is available yet for this article.
February 12, 2024: Drug and Therapeutics Bulletin
https://read.qxmd.com/read/38336461/very-low-calorie-diets-and-total-diet-replacement-in-type-2-diabetes-where-are-we-now
#8
REVIEW
Roy Taylor
Management of type 2 diabetes has now been simplified by the understanding that the condition is caused by excess fat in the liver together with suppression of beta cell function by the associated excess liver export of fat. These factors can be reversed by substantial weight loss leading to remission in the early years after diagnosis, or at least major decrease in cardiovascular risks and improvement in glucose control for all. Weight loss by any means is successful, but it is most easily achieved by rapid action using a low or very low calorie diet of around 800 kcal/day followed by sustained modest restraint of dietary habits...
February 9, 2024: Drug and Therapeutics Bulletin
https://read.qxmd.com/read/38326011/safety-update-omega-3-acid-ethyl-esters-and-atrial-fibrillation
#9
JOURNAL ARTICLE
(no author information available yet)
Overview of: Medicines and Healthcare products Regulatory Agency. Omega-3-acid ethyl ester medicines (Omacor/Teromeg 1000 mg capsules): dose-dependent increased risk of atrial fibrillation in patients with established cardiovascular diseases or cardiovascular risk factors. Drug Safety Update 2024;17(6):3.
February 7, 2024: Drug and Therapeutics Bulletin
https://read.qxmd.com/read/38326010/do-cox-inhibitors-improve-emergency-contraception-efficacy
#10
JOURNAL ARTICLE
(no author information available yet)
Overview of: Li RHW, Lo SST, Gemzell-Danielsson K, et al. Oral emergency contraception with levonorgestrel plus piroxicam: a randomised double-blind placebo-controlled trial [correction appears in Lancet 2023;402:850]. Lancet 2023;402:851-8.
February 7, 2024: Drug and Therapeutics Bulletin
https://read.qxmd.com/read/38316449/hydrocortisone-induced-symptomatic-sinus-bradycardia
#11
JOURNAL ARTICLE
Mohammed Ahmed, Success Tobore Oyibo, Shailesh Dalvi, Richard Cowell
No abstract text is available yet for this article.
February 5, 2024: Drug and Therapeutics Bulletin
https://read.qxmd.com/read/38302288/drug-induced-haemolysis-another-reason-to-be-cautious-with-nitrofurantoin
#12
JOURNAL ARTICLE
Chaitanya Bhatt, Zainab Doleeb, Priya Bapat, Christian Pagnoux
No abstract text is available yet for this article.
February 1, 2024: Drug and Therapeutics Bulletin
https://read.qxmd.com/read/38302287/severe-azathioprine-induced-liver-injury-22-months-after-initiation-of-treatment
#13
JOURNAL ARTICLE
Giovanni Cataletti, Fabrizio Santagata, Luca Pastorelli, Pier Maria Battezzati
No abstract text is available yet for this article.
February 1, 2024: Drug and Therapeutics Bulletin
https://read.qxmd.com/read/38302286/tramadol-warfarin-interaction
#14
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
February 1, 2024: Drug and Therapeutics Bulletin
https://read.qxmd.com/read/38296619/delirium-secondary-to-anticholinergics
#15
JOURNAL ARTICLE
Annalise Bellizzi, Elyse Mercieca, Catherine Dimech
No abstract text is available yet for this article.
January 31, 2024: Drug and Therapeutics Bulletin
https://read.qxmd.com/read/38296618/intravenous-acetaminophen-associated-with-acute-liver-failure
#16
JOURNAL ARTICLE
Maunoo Lee, Joshua McCarron, Aaron Balinski, Richard Bower
No abstract text is available yet for this article.
January 31, 2024: Drug and Therapeutics Bulletin
https://read.qxmd.com/read/38267080/adhd-medication-shortages-more-than-just-a-supply-issue
#17
EDITORIAL
Alexandra Lewis, Teck K Khong
No abstract text is available yet for this article.
January 24, 2024: Drug and Therapeutics Bulletin
https://read.qxmd.com/read/38527768/does-oseltamivir-prevent-hospitalisation-in-people-with-influenza
#18
JOURNAL ARTICLE
(no author information available yet)
Overview of: Hanula R, Bortolussi-Courval É, Mendel A, et al. Evaluation of oseltamivir used to prevent hospitalization in outpatients with influenza: a systematic review and meta-analysis. JAMA Internal Medicine 2024;184:18-27.
March 25, 2024: Drug and Therapeutics Bulletin
https://read.qxmd.com/read/38527767/effect-of-topical-testosterone-on-pre-diabetes-and-diabetes
#19
JOURNAL ARTICLE
(no author information available yet)
Overview of: Bhasin S, Lincoff AM, Nissen SE, et al. Effect of testosterone on progression from prediabetes to diabetes in men with hypogonadism: a substudy of the TRAVERSE randomized clinical trial. JAMA Intern Med. 2024. doi: 10.1001/jamainternmed.2023.7862. [Epub ahead of print 5 February 2024].
March 25, 2024: Drug and Therapeutics Bulletin
https://read.qxmd.com/read/38527766/slynd-does-a-drospirenone-progestogen-only-pill-offer-an-advantage
#20
REVIEW
(no author information available yet)
No abstract text is available yet for this article.
March 25, 2024: Drug and Therapeutics Bulletin
journal
journal
21685
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.